(Q44476207)

3 December 2017

title

Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report (English)

1 reference

3 December 2017

1 reference

Crookes P

1

1 reference

3 December 2017

Leichman CG

2

1 reference

3 December 2017

Leichman L

3

1 reference

3 December 2017

Tan M

4

1 reference

3 December 2017

Laine L

5

1 reference

3 December 2017

Stain S

6

1 reference

3 December 2017

Baranda J

7

1 reference

3 December 2017

Casagrande Y

8

1 reference

3 December 2017

Groshen S

9

1 reference

3 December 2017

Silberman H

10

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

3 December 2017

1 reference

3 December 2017

volume

79

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

1767-1775

1 reference

Gastric carcinoma. A ten-year review

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Biological modification of protracted infusion of 5-fluorouracil with weekly leucovorin. A dose seeking clinical trial for patients with disseminated gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970501%2979%3A9%3C1767%3A%3AAID-CNCR19%3E3.0.CO%3B2-W

10.1002/(SICI)1097-0142(19970501)79:9<1767::AID-CNCR19>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference